Skip to main content
Z

Zhejiang Huakang Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 605077 Shanghai Stock Exchange Manufacturing
Filings indexed 897 across all filing types
Latest filing 2025-10-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 605077

About Zhejiang Huakang Pharmaceutical Co., Ltd.

Zhejiang Huakang Pharmaceutical Co., Ltd. specializes in the research, development, and large-scale production of functional sugar alcohols. Its core product range includes xylitol, sorbitol, maltitol, erythritol, and xylose. These ingredients are primarily utilized as high-quality sugar substitutes and functional additives within the food, beverage, and personal care sectors. The company employs advanced hydrogenation and separation technologies to ensure high purity and consistency across its product lines. Huakang serves a global market, providing essential raw materials for the formulation of sugar-free and low-calorie consumer goods. The organization maintains a focus on technological innovation and quality management systems to meet international standards for safety and efficacy in ingredient manufacturing.

Recent filings

Filing Released Lang Actions
华康股份关于向不特定对象发行可转换公司债券募投项目结项的公告
Regulatory Filings
2025-10-28 Chinese
华康股份2025年第三季度报告
Regulatory Filings
2025-10-28 Chinese
华康股份关于注销首次公开发行股票募集资金专项账户的公告
Regulatory Filings
2025-10-22 Chinese
华康股份可转债转股结果暨股份变动公告
Regulatory Filings
2025-10-09 Chinese
华康股份关于转让参股公司股份已完成的公告
Regulatory Filings
2025-09-29 Chinese
华康股份关于召开2025年半年度业绩说明会的公告
Regulatory Filings
2025-09-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.